AI assistant
DEXCOM INC — Director's Dealing 2014
Mar 4, 2014
30198_dirs_2014-03-04_7b6cbe60-7fb0-4d0b-bb14-6bb45c6788cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-02-28
Reporting Person: GREGG TERRANCE H (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-28 | Common Stock | M | 15000.0 | $8.95 | Acquired | 227813 | Direct |
| 2014-02-28 | Common Stock | S | 15000.0 | $45.0758 | Disposed | 212813 | Direct |
| 2014-03-03 | Common Stock | M | 5000.0 | $3.19 | Acquired | 217813 | Direct |
| 2014-03-03 | Common Stock | S | 5000.0 | $44.5 | Disposed | 212813 | Direct |
| 2014-03-03 | Common Stock | M | 20000.0 | $13.99 | Acquired | 232813 | Direct |
| 2014-03-03 | Common Stock | S | 20000.0 | $44.8048 | Disposed | 212813 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-03 | Non-Qualified Stock Option (right to buy) | $3.19 | M | 5000.0 | Disposed | 2018-12-11 | Common Stock (5000) | Direct |
| 2014-02-28 | Non-Qualified Stock Option (right to buy) | $8.95 | M | 15000.0 | Disposed | 2018-01-02 | Common Stock (15000) | Direct |
| 2014-03-03 | Non-Qualified Stock Option (right to buy) | $13.99 | M | 20000.0 | Disposed | 2015-05-19 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
| Common Stock | 712889 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
F2: Included in this number are 126,954 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
F3: This transaction was executed in multiple trades at prices ranging from $44.50 to $45.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.